Quest Ventures

Quest Ventures is a Singapore-based venture firm with an explicit thesis around the digital economy and AI applications across Southeast Asia, operating from pre-seed through Series A with checks in the $250k to $1M range. Healthcare interest is expressed through digital health within a broader technology mandate, and AI is implicitly central to the fund’s positioning even if not explicitly flagged in the source data for healthcare. The fund has built deep operator networks across Singapore, Vietnam, Indonesia, Malaysia, and the Philippines, with a particular strength in cross-border deal flow between Southeast Asia and China. The right founder for Quest is a Southeast Asian operator building a digital health, telehealth, or healthcare AI business with strong founder-market fit, credible regional ambition, and unit economics that work at the relatively small early check sizes Quest provides. The wrong founder is a deep medtech or therapeutics team, a Series A-plus company looking for institutional lead, or a US-pedigreed founder without local market thesis. Intro paths run through Singapore’s tight venture community including Wavemaker Partners, Insignia Ventures, Openspace Ventures, and 500 Global Southeast Asia, and through Quest’s existing regional portfolio CEOs. The fund’s China-Southeast Asia bridge networks are also a distinctive intro vector for founders with that strategic ambition. Direct outreach is read but warm intros materially help. In the pitch, lead with cohort retention, real customer evidence, and a credible cross-border expansion logic across at least two Southeast Asian markets. Be specific about regulatory posture in your primary markets, including PDPA Singapore, MOH Singapore, BPOM Indonesia, FDA Philippines, and MOH Vietnam as relevant. Show realistic unit economics that work at the early check sizes and demonstrate a credible plan for follow-on capital. Caveats include the modest check size which means Quest is rarely a sole lead in competitive rounds, the increased competitiveness of Southeast Asian early-stage venture in 2024-2025, and the reality that the fund’s thesis breadth across the digital economy means healthcare-specific support is less specialized than at dedicated health funds. The fit is good for digitally-native Southeast Asian healthcare operators with regional ambition.